{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:57:16Z","timestamp":1791309436795,"version":"4.3.1"},"reference-count":25,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome usually caused by oversecretion of fibroblast growth factor 23 (FGF23) from a phosphaturic mesenchymal tumor (PMT). PMTs are usually benign neoplasms but some of them show malignant characteristics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The aim of this study was to compare the clinical characteristics of benign and malignant PMTs inducing TIO.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>On March 31, 2023, we performed a systematic review of individual patient data analysis in Medline, Google Scholar, Google book, and Cochrane Library using the terms \u201ctumor induced osteomalacia,\u201d \u201concogenic osteomalacia,\u201d \u201chypophosphatemia,\u201d with no language restrictions and according to Preferred Reporting Items for Systematic reviews and Meta-Analyses criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, we collected data from 837 patients with TIO in which the diagnosis of benign and malignant PMT was specified. Of them, 89 were affected by malignant PMT and 748 by benign PMT. Patients with malignant PMTs were younger and presented bone pain, functional impairment, and bone deformities more frequently. Malignant PMTs showed higher values of intact FGF23 and a higher mortality rate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The study results identify the clinical characteristics of patients with malignant TIO, permitting the early identification of patients with PMT at increased risk of malignancy. This may significantly improve the diagnostic approach to disease. Further experimental studies are mandatory to clarify the role of FGF23 in the pathogenesis of malignancy in PMTs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgad690","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T12:23:43Z","timestamp":1700915023000},"page":"e1006-e1011","source":"Crossref","is-referenced-by-count":22,"title":["Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0085-0067","authenticated-orcid":false,"given":"Veronica","family":"Abate","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d , 80131 Naples , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6574-9120","authenticated-orcid":false,"given":"Anita","family":"Vergatti","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d , 80131 Naples , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1313-5599","authenticated-orcid":false,"given":"Gianpaolo","family":"De Filippo","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Robert-Debr\u00e9, Service d'Endocrinologie-Diab\u00e9tologie , 75019 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Damiano","sequence":"additional","affiliation":[{"name":"Clinical Department of Oncology and Hematology, University of Naples \u201cFederico II\u201d , 80131 Naples , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Menale","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d , 80131 Naples , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1782-0211","authenticated-orcid":false,"given":"Lanfranco","family":"D\u2019Elia","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d , 80131 Naples , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0331-0392","authenticated-orcid":false,"given":"Domenico","family":"Rendina","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d , 80131 Naples , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,11,25]]},"reference":[{"issue":"8","key":"2024022001131003200_dgad690-B1","doi-asserted-by":"crossref","first-page":"e3428","DOI":"10.1210\/clinem\/dgac253","article-title":"Tumor-induced osteomalacia: a systematic review and individual patient's data analysis","volume":"107","author":"Rendina","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024022001131003200_dgad690-B2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/j.semdp.2019.07.002","article-title":"Phosphaturic mesenchymal tumors: a review and update","volume":"36","author":"Folpe","year":"2019","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"2024022001131003200_dgad690-B3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00424-022-02668-w","article-title":"The regulation of FGF23 under physiological and pathophysiological conditions","volume":"474","author":"Rausch","year":"2022","journal-title":"Pflugers Arch"},{"issue":"7","key":"2024022001131003200_dgad690-B4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0192623317737469","article-title":"Pleiotropic actions of FGF23","volume":"45","author":"Erben","year":"2017","journal-title":"Toxicol Pathol"},{"issue":"1","key":"2024022001131003200_dgad690-B5","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","article-title":"Tumour-induced osteomalacia","volume":"3","author":"Minisola","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"2024022001131003200_dgad690-B6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"de Beur SM","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024022001131003200_dgad690-B7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/js.2016-1088","article-title":"Peptide receptor radionuclide and octreotide: a novel approach for metastatic tumor-induced osteomalacia","volume":"1","author":"Nair","year":"2017","journal-title":"J Endocr Soc"},{"issue":"3","key":"2024022001131003200_dgad690-B8","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1159\/000510334","article-title":"Peptide receptor radionuclide therapy for a phosphaturic mesenchymal tumor","volume":"13","author":"H\u00e4fliger","year":"2020","journal-title":"Case Rep Oncol"},{"issue":"12","key":"2024022001131003200_dgad690-B9","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1158\/0008-5472.CAN-19-0458","article-title":"Defining the hallmarks of metastasis","volume":"79","author":"Welch","year":"2019","journal-title":"Cancer Res"},{"issue":"1","key":"2024022001131003200_dgad690-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"25","key":"2024022001131003200_dgad690-B11","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMra0904186","article-title":"Genetic disorders of renal phosphate transport","volume":"362","author":"Pri\u00e9","year":"2010","journal-title":"N Engl J Med"},{"key":"2024022001131003200_dgad690-B12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-88-470-1095-6_9","volume-title":"Multiple Primary Malignancies. Updates in Surgery","author":"de Werra","year":"2009"},{"key":"2024022001131003200_dgad690-B13","author":"Abate"},{"issue":"2","key":"2024022001131003200_dgad690-B14","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1530\/JME-20-0178","article-title":"FGF23 signalling and physiology","volume":"66","author":"Ho","year":"2021","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"2024022001131003200_dgad690-B15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bju.12396","article-title":"Single nucleotide polymorphisms in fibroblast growth factor 23 gene, FGF23, are associated with prostate cancer risk","volume":"114","author":"Kim","year":"2014","journal-title":"BJU Int"},{"issue":"5","key":"2024022001131003200_dgad690-B16","doi-asserted-by":"crossref","first-page":"E840","DOI":"10.1210\/jc.2011-1528","article-title":"A functional allelic variant of the FGF23 gene is associated with renal phosphate leak in calcium nephrolithiasis","volume":"97","author":"Rendina","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024022001131003200_dgad690-B17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2024022001131003200_dgad690-B18","doi-asserted-by":"crossref","first-page":"210373","DOI":"10.1098\/rsob.210373","article-title":"Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer","volume":"12","author":"Francavilla","year":"2022","journal-title":"Open Biol"},{"issue":"4","key":"2024022001131003200_dgad690-B19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1817323","article-title":"Erdafitinib in locally advanced or metastatic urothelial carcinoma","volume":"381","author":"Loriot","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"2024022001131003200_dgad690-B20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.clgc.2022.05.007","article-title":"Phase 2 study of neoadjuvant FGFR inhibition and androgen deprivation therapy prior to prostatectomy","volume":"20","author":"Liow","year":"2022","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"2024022001131003200_dgad690-B21","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"21","key":"2024022001131003200_dgad690-B22","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.7150\/jca.47175","article-title":"Association between kidney function and the risk of cancer: results from the China health and retirement longitudinal study (CHARLS)","volume":"11","author":"Liu","year":"2020","journal-title":"J Cancer"},{"issue":"8","key":"2024022001131003200_dgad690-B23","doi-asserted-by":"crossref","first-page":"e0272910","DOI":"10.1371\/journal.pone.0272910","article-title":"Risk of malignancy in patients with chronic kidney disease","volume":"17","author":"Tendulkar","year":"2022","journal-title":"PLoS One"},{"issue":"3","key":"2024022001131003200_dgad690-B24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3390\/ijms20030695","article-title":"Levels of circulating fibroblast growth factor 23 (FGF23) and prognosis in cancer patients with bone metastases","volume":"20","author":"Mansinho","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"feb05 1","key":"2024022001131003200_dgad690-B25","doi-asserted-by":"crossref","first-page":"c221","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: rationale, conduct, and reporting","volume":"340","author":"Riley","year":"2010","journal-title":"BMJ"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad690\/54078604\/dgad690.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/3\/e1006\/56680965\/dgad690.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/3\/e1006\/56680965\/dgad690.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T01:15:55Z","timestamp":1708391755000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/3\/e1006\/7450929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,25]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,11,25]]},"published-print":{"date-parts":[[2024,2,20]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad690","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2023,11,25]]}}}